Analysis of the effect of sacubitril valsartan sodium tablets in the treatment of hypertension
沙库巴曲缬沙坦钠片治疗高血压的效果分析

摘要

目的 分析在高血压患者药物方案中应用沙库巴曲缬沙坦钠片治疗的医学价值。方法 将2022年1月-2023年12月内就诊的高血压者90例纳入试验研究，而后以区组随机法分45例对照组应用缬沙坦治疗，45例观察组联合沙库巴曲缬沙坦钠片治疗。在不同护理药物差异下，以治疗前后的血压以及不良反应对比治疗价值。结果 治疗前，两组患者血压指标对比无统计学意义（P﹥0.05）。治疗后，观察组血压指标相较对照组更优，对比有统计学意义（P﹤0.05），但不良反应对比无统计学意义（P﹥0.05）。结论 沙库巴曲缬沙坦钠片治疗高血压效果好，且无严重不良反应，用药安全性高。

Abstract

Objective To analyze the medical value of using sacubitril valsartan sodium tablets in the treatment of hypertension patients.
Methods A total of 90 hypertensive patients who received treatment between January 2022 and December 2023 were included in the experimental study. Then, they were randomly divided into a control group of 45 patients who received valsartan treatment and an observation group of 45 patients who received combined treatment with sacubitril and valsartan sodium tablets. Compare the therapeutic value of blood pressure and adverse reactions before and after treatment under different nursing medication differences.
Results Before treatment, there was no statistically significant difference in blood pressure indicators between the two groups of patients (P>0.05). After treatment, the blood pressure indicators in the observation group were better than those in the control group, with statistical significance (P<0.05), but there was no statistical significance in the comparison of adverse reactions (P>0.05).
Conclusion   Sacubitril valsartan sodium tablets have a good therapeutic effect on hypertension, with no serious adverse reactions and high medication safety.